3D-Printed Ceramic-Demineralized Bone Matrix Hyperelastic Bone Composite Scaffolds for Spinal Fusion.

Current bone graft substitutes for spinal fusion face limitations in cost, safety, and effectiveness. While several commercial options exist, none have been proven to achieve high fusion rates without the use of recombinant growth factors. Prior research has shown that hydroxyapatite (HA) supports bone conduction, and demineralized bone matrix (DBM) offers osteoinductive properties. However, combining these materials in a scaffold format has not been thoroughly explored. No prior work had resolved how HA and DBM interact in a 3D-printed composite to promote fusion. This gap motivated the development of a composite scaffold that could potentially replace traditional grafts. The study aimed to evaluate whether a 3D-printed scaffold with HA and DBM could achieve successful fusion without growth factors. The need for a safe, effective, and cost-efficient alternative remains unmet in clinical practice.

The study aimed to develop and test a 3D-printed scaffold made of hydroxyapatite and demineralized bone matrix for spinal fusion. The goal was to determine whether this composite could promote successful fusion without the need for recombinant growth factors. The researchers proposed that combining HA and DBM in a scaffold could enhance osteointegration and bone formation. The specific problem addressed was the lack of a safe and effective bone graft substitute for spine fusion. The motivation stemmed from the limitations of current commercial biologics, which often require additional growth factors or fail to achieve high fusion rates. The study sought to evaluate the osteoinductive and osteoconductive properties of the composite material. The researchers also aimed to compare the performance of HA:DBM composites with DBM-only scaffolds. The ultimate objective was to identify a viable alternative for spinal fusion that could improve patient outcomes.

The researchers created 3D-printed scaffolds using a composite of hydroxyapatite and demineralized bone matrix in a poly(lactide-co-glycolide) elastomer. The scaffolds were printed with varying volumetric ratios of HA and DBM. The study used a rat model to evaluate spine fusion outcomes. Fusion success was assessed through manual palpation and microcomputed tomography. Histological analysis was conducted to examine osteointegration and new bone formation. The researchers evaluated scaffold struts for the presence of bone-like spicules. Synchrotron microcomputed tomography provided detailed imaging of bone growth within the scaffolds. The study compared fusion rates and osteointegration scores across different scaffold compositions.

The 3:1 HA:DBM composite achieved the highest mean fusion score and fusion rate of 92%, significantly higher than the 42% observed in DBM-only scaffolds. New bone extended from the host transverse processes into scaffold macropores. Osteointegration scores correlated with successful fusion outcomes. Bone-like spicules formed within the DBM particles inside scaffold struts. These spicules were absent in DBM-only scaffolds, indicating that HA and DBM together are necessary for spicule formation. The composite material demonstrated superior osteoinductive and osteoconductive properties. The study found that HA and DBM in a 3:1 ratio promoted the highest levels of bone formation. The results suggest that the composite could serve as a growth factor-free alternative for spinal fusion.

The study suggests that the 3:1 HA:DBM composite scaffold promotes successful spinal fusion without recombinant growth factors. The material achieved a high fusion rate of 92%, significantly better than DBM-only scaffolds. Bone-like spicules formed within the composite, indicating enhanced osteoinductive properties. The researchers propose that the combination of HA and DBM is necessary for spicule formation. The composite material demonstrated strong osteoconductive and osteoinductive effects. The findings suggest that this scaffold could overcome limitations of current bone graft substitutes. The study supports the potential of this material for clinical use in spinal fusion. The authors claim that this composite shows promise as a safe and effective alternative for spine fusion procedures.